Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
17
AGAE Quote, Financials, Valuation and Earnings
Last price:
$1.70
Seasonality move
:
-23.72%
Day range:
$1.48 - $1.80
52-week range:
$0.70 - $3.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.92x
P/B ratio:
0.95x
Volume:
72K
Avg. volume:
107.1K
1-year change:
23.02%
Market cap:
$65M
Revenue:
$9.1M
EPS (TTM):
-$0.27
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.2M | $5M | $6.4M | $7.7M | $9.1M | |
| Revenue Growth (YoY) | -57.46% | 54.36% | 28.18% | 20.51% | 18.6% | |
| Cost of Revenues | $2.9M | $4.1M | $4.8M | $4.8M | $6.4M | |
| Gross Profit | $347.9K | $880.8K | $1.5M | $2.9M | $2.7M | |
| Gross Profit Margin | 10.84% | 17.77% | 24.25% | 37.35% | 29.81% | |
| R&D Expenses | -- | -- | -- | $162.9K | $865.6K | |
| Selling, General & Admin | $16.5M | $13.3M | $11M | $7.8M | $13.6M | |
| Other Inc / (Exp) | -$20.2M | $981.4K | -$78.9K | $46.7K | -$13.3M | |
| Operating Expenses | $20.3M | $16.7M | $13.1M | $9.5M | $16.1M | |
| Operating Income | -$20M | -$15.8M | -$11.5M | -$6.6M | -$13.4M | |
| Net Interest Expenses | $5.5M | $268.8K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$45.8M | -$15.1M | -$10.8M | -$3.6M | -$23M | |
| Earnings of Discontinued Ops. | $725.5K | $77.9M | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -$425.4K | |
| Net Income to Company | -$45.1M | $62.9M | -$10.8M | -$3.6M | -$22.6M | |
| Minority Interest in Earnings | -- | -- | -- | $159.9K | $5.8M | |
| Net Income to Common Excl Extra Items | -$45.1M | $62.9M | -$10.8M | -$3.4M | -$16.8M | |
| Basic EPS (Cont. Ops) | -$1.57 | $1.61 | -$0.28 | -$0.09 | -$0.42 | |
| Diluted EPS (Cont. Ops) | -$1.57 | $1.61 | -$0.28 | -$0.09 | -$0.42 | |
| Weighted Average Basic Share | $28.7M | $39M | $39.1M | $37.2M | $40.4M | |
| Weighted Average Diluted Share | $28.7M | $39M | $39.1M | $37.2M | $40.4M | |
| EBITDA | -$36.6M | -$12.5M | -$9.5M | -$5.1M | -$11.8M | |
| EBIT | -$40.2M | -$15.8M | -$11.5M | -$6.6M | -$13.4M | |
| Revenue (Reported) | $3.2M | $5M | $6.4M | $7.7M | $9.1M | |
| Operating Income (Reported) | -$20M | -$15.8M | -$11.5M | -$6.6M | -$13.4M | |
| Operating Income (Adjusted) | -$40.2M | -$15.8M | -$11.5M | -$6.6M | -$13.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $501K | $2.4M | $1.2M | $2.4M | $2.3M | |
| Revenue Growth (YoY) | -52.63% | 381.42% | -50.52% | 99.35% | -4.37% | |
| Cost of Revenues | $537.9K | $1.8M | $672.6K | $1.6M | $1.4M | |
| Gross Profit | -$36.8K | $580.6K | $520.8K | $806.2K | $832.4K | |
| Gross Profit Margin | -7.35% | 24.07% | 43.64% | 33.89% | 36.59% | |
| R&D Expenses | -- | -- | -- | $195.2K | $181K | |
| Selling, General & Admin | $4M | $3.5M | $2.6M | $2.9M | $5.5M | |
| Other Inc / (Exp) | $55.1K | -$6.7K | $27.5K | -$13.2K | -$512.6K | |
| Operating Expenses | $4.8M | $4.3M | $3.2M | $3.5M | $6.1M | |
| Operating Income | -$4.9M | -$3.7M | -$2.7M | -$2.7M | -$5.3M | |
| Net Interest Expenses | $153.1K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$5M | -$3.8M | -$1.9M | -$1.8M | -$4.9M | |
| Earnings of Discontinued Ops. | $1.6M | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$3.3M | -$3.8M | -$1.9M | -$1.8M | -$4.9M | |
| Minority Interest in Earnings | -- | -- | -- | $130.3K | $63.4K | |
| Net Income to Common Excl Extra Items | -$3.3M | -$3.8M | -$1.9M | -$1.7M | -$4.8M | |
| Basic EPS (Cont. Ops) | -$0.09 | -$0.10 | -$0.05 | -$0.04 | -$0.11 | |
| Diluted EPS (Cont. Ops) | -$0.09 | -$0.10 | -$0.05 | -$0.04 | -$0.11 | |
| Weighted Average Basic Share | $39M | $39.1M | $37.9M | $38.9M | $43.5M | |
| Weighted Average Diluted Share | $39M | $39.1M | $37.9M | $38.9M | $43.5M | |
| EBITDA | -$4M | -$2.9M | -$2.1M | -$2.3M | -$4.9M | |
| EBIT | -$4.9M | -$3.7M | -$2.7M | -$2.7M | -$5.3M | |
| Revenue (Reported) | $501K | $2.4M | $1.2M | $2.4M | $2.3M | |
| Operating Income (Reported) | -$4.9M | -$3.7M | -$2.7M | -$2.7M | -$5.3M | |
| Operating Income (Adjusted) | -$4.9M | -$3.7M | -$2.7M | -$2.7M | -$5.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7M | $6.9M | $5.1M | $8.8M | $9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.4M | $5.4M | $3.8M | $5.7M | $6.2M | |
| Gross Profit | $240.8K | $1.5M | $1.3M | $3.1M | $2.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | $358.1K | $851.3K | |
| Selling, General & Admin | $13M | $13.9M | $9.9M | $8.1M | $16.2M | |
| Other Inc / (Exp) | -$20.2M | $919.5K | -$44.7K | $6.1K | -$13.8M | |
| Operating Expenses | $16.7M | $17.1M | $11.8M | $9.8M | $18.7M | |
| Operating Income | -$16.5M | -$15.6M | -$10.4M | -$6.6M | -$16M | |
| Net Interest Expenses | $5M | $111.2K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$41.7M | -$14.8M | -$9M | -$3.5M | -$26.1M | |
| Earnings of Discontinued Ops. | $2.1M | $77.3M | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$39.6M | $62.5M | -$9M | -$3.5M | -$25.6M | |
| Minority Interest in Earnings | -- | -- | -- | $290.2K | $5.8M | |
| Net Income to Common Excl Extra Items | -$39.6M | $62.5M | -$9M | -$3.2M | -$19.9M | |
| Basic EPS (Cont. Ops) | -$1.31 | $1.56 | -$0.22 | -$0.09 | -$0.49 | |
| Diluted EPS (Cont. Ops) | -$1.31 | $1.56 | -$0.22 | -$0.09 | -$0.49 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$33.2M | -$12.4M | -$8.6M | -$5.3M | -$14.4M | |
| EBIT | -$36.7M | -$15.6M | -$10.4M | -$6.6M | -$16M | |
| Revenue (Reported) | $2.7M | $6.9M | $5.1M | $8.8M | $9M | |
| Operating Income (Reported) | -$16.5M | -$15.6M | -$10.4M | -$6.6M | -$16M | |
| Operating Income (Adjusted) | -$36.7M | -$15.6M | -$10.4M | -$6.6M | -$16M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $501K | $2.4M | $1.2M | $2.4M | $2.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $537.9K | $1.8M | $672.6K | $1.6M | $1.4M | |
| Gross Profit | -$36.8K | $580.6K | $520.8K | $806.2K | $832.4K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | $195.2K | $181K | |
| Selling, General & Admin | $4M | $3.5M | $2.6M | $2.9M | $5.5M | |
| Other Inc / (Exp) | $55.1K | -$6.7K | $27.5K | -$13.2K | -$512.6K | |
| Operating Expenses | $4.8M | $4.3M | $3.2M | $3.5M | $6.1M | |
| Operating Income | -$4.9M | -$3.7M | -$2.7M | -$2.7M | -$5.3M | |
| Net Interest Expenses | $153.1K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$5M | -$3.8M | -$1.9M | -$1.8M | -$4.9M | |
| Earnings of Discontinued Ops. | $1.6M | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$3.3M | -$3.8M | -$1.9M | -$1.8M | -$4.9M | |
| Minority Interest in Earnings | -- | -- | -- | $130.3K | $63.4K | |
| Net Income to Common Excl Extra Items | -$3.3M | -$3.8M | -$1.9M | -$1.7M | -$4.8M | |
| Basic EPS (Cont. Ops) | -$0.09 | -$0.10 | -$0.05 | -$0.04 | -$0.11 | |
| Diluted EPS (Cont. Ops) | -$0.09 | -$0.10 | -$0.05 | -$0.04 | -$0.11 | |
| Weighted Average Basic Share | $39M | $39.1M | $37.9M | $38.9M | $43.5M | |
| Weighted Average Diluted Share | $39M | $39.1M | $37.9M | $38.9M | $43.5M | |
| EBITDA | -$4M | -$2.9M | -$2.1M | -$2.3M | -$4.9M | |
| EBIT | -$4.9M | -$3.7M | -$2.7M | -$2.7M | -$5.3M | |
| Revenue (Reported) | $501K | $2.4M | $1.2M | $2.4M | $2.3M | |
| Operating Income (Reported) | -$4.9M | -$3.7M | -$2.7M | -$2.7M | -$5.3M | |
| Operating Income (Adjusted) | -$4.9M | -$3.7M | -$2.7M | -$2.7M | -$5.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $424.2K | $92.9M | $11.2M | $16.3M | $59.2M | |
| Short Term Investments | -- | -- | $70M | $56.5M | $12.3M | |
| Accounts Receivable, Net | $271.1K | $389K | $72.7K | $529.4K | $708.8K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | $3.7M | $3.7M | |
| Other Current Assets | $909.8K | $984.8K | $459.3K | $498.9K | $471.4K | |
| Total Current Assets | $47M | $94.3M | $82.4M | $78.3M | $94.7M | |
| Property Plant And Equipment | $9.3M | $6.1M | $9.9M | $9.2M | $7.4M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | $12.7M | $2.8M | |
| Other Intangibles | $30.8K | $26.8K | $72.6K | $6.3M | $5.2M | |
| Other Long-Term Assets | $5M | $5M | $5M | $5M | -- | |
| Total Assets | $61.9M | $105.8M | $97.7M | $112M | $112.7M | |
| Accounts Payable | $901.4K | $341.2K | $317.6K | $371.8K | $1.3M | |
| Accrued Expenses | $1.1M | $2.4M | $98.5K | $108K | $882.3K | |
| Current Portion Of Long-Term Debt | $2.5M | -- | -- | $9.2M | $25.8M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $1.2M | $1.5M | $1.6M | |
| Other Current Liabilities | $9.2M | $14.7K | $100 | $100 | -- | |
| Total Current Liabilities | $25.7M | $5.2M | $3.3M | $12M | $30.5M | |
| Long-Term Debt | $946.3K | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $28.5M | $7.2M | $9.8M | $18.6M | $35.2M | |
| Common Stock | $3.9K | $3.9K | $3.9K | $3.9K | $4.6K | |
| Other Common Equity Adj | $191K | $269.6K | $219.7K | $433.6K | $180K | |
| Common Equity | $33.4M | $98.6M | $87.9M | $82.7M | $73M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | $10.7M | $4.5M | |
| Total Equity | $33.4M | $98.6M | $87.9M | $93.4M | $77.5M | |
| Total Liabilities and Equity | $61.9M | $105.8M | $97.7M | $112M | $112.7M | |
| Cash and Short Terms | $424.2K | $92.9M | $81.2M | $72.8M | $71.5M | |
| Total Debt | $4.9M | -- | -- | $9.2M | $25.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10.5M | $90.7M | $3.6M | $7.3M | $19.5M | |
| Short Term Investments | -- | -- | $74.5M | $69.6M | $51.3M | |
| Accounts Receivable, Net | $62.3K | $889.9K | $306.4K | $477.8K | $274.9K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | $3.7M | $3.7M | |
| Other Current Assets | $618.9K | $802.3K | $724.1K | $550.6K | $496.6K | |
| Total Current Assets | $63.5M | $92.4M | $80.4M | $84.3M | $98M | |
| Property Plant And Equipment | $8.4M | $5.3M | $9.1M | $8.7M | $6.9M | |
| Long-Term Investments | -- | -- | -- | -- | $2.5M | |
| Goodwill | -- | -- | -- | $12.5M | $2.8M | |
| Other Intangibles | $29.8K | $244.6K | $636.2K | $6.1M | $5.1M | |
| Other Long-Term Assets | -- | $5M | $5.1M | $5M | -- | |
| Total Assets | $72.6M | $103.4M | $95.6M | $117M | $117.9M | |
| Accounts Payable | $1.1M | $388.2K | $538.2K | $173K | $2.7M | |
| Accrued Expenses | $1.1M | $2.8M | $326.6K | $163.1K | $1.5M | |
| Current Portion Of Long-Term Debt | $2.8M | -- | -- | $14.9M | $34.5M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $1.3M | $1.5M | $1.6M | |
| Other Current Liabilities | $19.4M | $35.2K | $100 | $100 | -- | |
| Total Current Liabilities | $39.2M | $6M | $4.9M | $17.1M | $40.7M | |
| Long-Term Debt | $92.2K | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $41.1M | $8.1M | $11.1M | $23.4M | $45M | |
| Common Stock | $3.9K | $3.9K | $3.9K | $4.8K | $4.6K | |
| Other Common Equity Adj | $216.3K | $282.6K | $221.6K | $299.9K | $222.1K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | $10.3M | $4.5M | |
| Total Equity | $31.5M | $95.3M | $84.6M | $93.6M | $72.9M | |
| Total Liabilities and Equity | $72.6M | $103.4M | $95.6M | $117M | $117.9M | |
| Cash and Short Terms | $10.5M | $90.7M | $78.1M | $76.9M | $70.8M | |
| Total Debt | $4.3M | -- | -- | $14.9M | $34.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$45.1M | $62.9M | -$10.8M | -$3.6M | -$22.6M | |
| Depreciation & Amoritzation | $3.6M | $3.3M | $2.1M | $1.5M | $1.6M | |
| Stock-Based Compensation | $5.1M | $1.3M | $791.3K | $150.5K | $1.1M | |
| Change in Accounts Receivable | $361.9K | -$118.7K | -$361.7K | -$262.4K | -$97.8K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5.2M | -$10.1M | -$10.9M | -$8.1M | -$9.8M | |
| Capital Expenditures | $356.5K | $191.7K | $94.3K | $1M | $2.4M | |
| Cash Acquisitions | -- | $106M | -- | -$6.4M | -- | |
| Cash From Investing | -$5.5M | $105.9M | -$70.1M | $6.1M | $23.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $9.9M | -- | -- | $9.2M | $26M | |
| Long-Term Debt Repaid | -$7M | -$3.4M | -- | -- | -$8.5M | |
| Repurchase of Common Stock | -- | -- | -$610.6K | -$2.1M | -$2M | |
| Other Financing Activities | -$745.1K | -- | -- | -- | -$247.7K | |
| Cash From Financing | $9.2M | -$3.4M | -$610.6K | $7.1M | $23.9M | |
| Beginning Cash (CF) | $6.9M | $5.4M | $97.9M | $16.2M | $21.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.5M | $92.4M | -$81.7M | $5.1M | $38M | |
| Ending Cash (CF) | $5.4M | $97.9M | $16.2M | $21.3M | $59.2M | |
| Levered Free Cash Flow | -$5.5M | -$10.3M | -$11M | -$9.2M | -$12.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.3M | -$3.8M | -$1.9M | -$1.8M | -$4.9M | |
| Depreciation & Amoritzation | $882K | $808.6K | $578.6K | $373.7K | $374.7K | |
| Stock-Based Compensation | $643.2K | $401.3K | $5.1K | $471.6K | $188.4K | |
| Change in Accounts Receivable | $207.9K | -$501.7K | -$858.5K | -$471.9K | $275.4K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $87.5K | -$2.1M | -$1M | -$2.1M | -$2.2M | |
| Capital Expenditures | $10.2K | $9.4K | $595.4K | $10.6K | $32.3K | |
| Cash Acquisitions | $10M | -- | -- | -- | -- | |
| Cash From Investing | $10M | -$50.5K | -$5.1M | -$14.5M | -$45.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $5.6M | $19.2M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$11.7M | |
| Repurchase of Common Stock | -- | -- | -$1.5M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -$1.5M | $7.6M | $7.5M | |
| Beginning Cash (CF) | $5.4M | $97.9M | $16.2M | $21.3M | $59.2M | |
| Foreign Exchange Rate Adjustment | $41.5K | $16.7K | $7.3K | -$7.8K | $13.4K | |
| Additions / Reductions | $10.1M | -$2.2M | -$7.6M | -$9M | -$39.8M | |
| Ending Cash (CF) | $15.5M | $95.7M | $8.6M | $12.3M | $19.5M | |
| Levered Free Cash Flow | $77.3K | -$2.1M | -$1.6M | -$2.2M | -$2.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$39.6M | $62.5M | -$9M | -$3.5M | -$25.6M | |
| Depreciation & Amoritzation | $3.6M | $3.2M | $1.8M | $1.3M | $1.6M | |
| Stock-Based Compensation | $1.8M | $1.1M | $395.1K | $617K | $816.1K | |
| Change in Accounts Receivable | $68.3K | -$828.3K | -$718.5K | $124.2K | $649.5K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$4.4M | -$12.3M | -$9.8M | -$9.3M | -$9.8M | |
| Capital Expenditures | $141.7K | $190.9K | $680.3K | $462.2K | $2.4M | |
| Cash Acquisitions | $10M | $96M | -- | -- | -- | |
| Cash From Investing | $9.9M | $95.8M | -$75.2M | -$3.3M | -$6.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $14.9M | $39.6M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -$2.1M | -$624K | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -$3.4M | -$2.1M | $16.2M | $23.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.6M | $80.1M | -$87.1M | $3.7M | $7.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$4.5M | -$12.5M | -$10.5M | -$9.7M | -$12.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.3M | -$3.8M | -$1.9M | -$1.8M | -$4.9M | |
| Depreciation & Amoritzation | $882K | $808.6K | $578.6K | $373.7K | $374.7K | |
| Stock-Based Compensation | $643.2K | $401.3K | $5.1K | $471.6K | $188.4K | |
| Change in Accounts Receivable | $207.9K | -$501.7K | -$858.5K | -$471.9K | $275.4K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $87.5K | -$2.1M | -$1M | -$2.1M | -$2.2M | |
| Capital Expenditures | $10.2K | $9.4K | $595.4K | $10.6K | $32.3K | |
| Cash Acquisitions | $10M | -- | -- | -- | -- | |
| Cash From Investing | $10M | -$50.5K | -$5.1M | -$14.5M | -$45.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $5.6M | $19.2M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$11.7M | |
| Repurchase of Common Stock | -- | -- | -$1.5M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -$1.5M | $7.6M | $7.5M | |
| Beginning Cash (CF) | $5.4M | $97.9M | $16.2M | $21.3M | $59.2M | |
| Foreign Exchange Rate Adjustment | $41.5K | $16.7K | $7.3K | -$7.8K | $13.4K | |
| Additions / Reductions | $10.1M | -$2.2M | -$7.6M | -$9M | -$39.8M | |
| Ending Cash (CF) | $15.5M | $95.7M | $8.6M | $12.3M | $19.5M | |
| Levered Free Cash Flow | $77.3K | -$2.1M | -$1.6M | -$2.2M | -$2.2M | |
Get AGAE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AGAE
Sector
P/E ratio
--
16.92x
PEG ratio
-0.01x
0.17x
P/B ratio
0.95x
1.42x
Price / LTM sales
7.92x
0.68x
Growth Metrics
AGAE
Sector
Revenue growth
93.18%
0.64%
Earnings growth
--
-1.02%
Revenue (5-year growth)
3.76%
3.61%
Earnings forecast
--
$0.24
Profitability
AGAE
Sector
Profitability FY 2024
$2.7M
$456.7M
Return on invested capital
-9.95%
4.58%
Return on assets
-9.19%
2.72%
Return on equity
-11.98%
6.7%
Earnings Date
Last Earnings Date
Jul
7
Next Earnings Date
Aug
19
Estimated Next Earnings Date
Oct
6
Balance Sheet
AGAE
Sector
Total cash
$77.7M
$139.6M
Short term investments
$12.3M
$46.8M
Total assets
$112.7M
$1.4B
Long term debt
$37.3M
$128.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
